Talk:Prescription drug prices in the United States

From Wikipedia, the free encyclopedia

	Prescription drug prices in the United States is part of WikiProject Pharmacology, a project to improve all Pharmacology-related articles. If you would like to help improve this and other pharmacology articles, please join the project. All interested editors are welcome.

This is the talk page for discussing improvements to the Prescription drug prices in the United States article. This is not a forum for general discussion about the article's subject.
Please sign and date your posts by typing four tildes (~~~~). Put new text under old text. Click here to start a new topic. New to Wikipedia? Welcome! Ask questions, get answers.	Be polite Assume good faith No personal attacks Be welcoming	Article policies No original research Neutral point of view Verifiability

[edit] Comment

Clearly only one point of view is reasonably expressed in this article. Perhaps someone familiar with the pharmaceutical/medical community's point of view can provide balance.—The preceding unsigned comment was added by Deli nk (talk • contribs) 13:27, 17 January 2006 (UTC).

Err, it appears to me that *only* the pharmaceutical point of view is presented. For instance, the article bemoans that only 11% of drugs make it past clinical trials, but it fails to mention that the vast majority of most drug companies' money (I believe it is around 2/3, though I do not have a source handy) is spent on advertising instead of R&D. Lode Runner 13:17, 29 August 2006 (UTC)

Leaving beside the political isses, I would be interested in someone explaining how drug prices are negotiated between drug companies, distributors, pharmacy chains, insurance companies, medicare, medicaide etc. I understand it's quite a complicated process. The net result is that the price for the same drug can vary by 2X depending upon a number of factors.--Nowa 22:54, 2 January 2007 (UTC)